Larimar Therapeutics Inc. – Underwriting Agreements

NASDAQ: LRMR
Share price (9/23/26): $3.87
Market cap (9/23/26): $402 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 51 pages 20,000,000 Shares of Common Stock Larimar Therapeutics, Inc. Underwriting Agreement

from 8-K 50 pages 18,750,000 Shares of Common Stock Larimar Therapeutics, Inc. Underwriting Agreement

from S-3 42 pages Larimar Therapeutics, Inc. Sales Agreement

from 8-K 44 pages 17,162,472 Shares of Common Stock Larimar Therapeutics, Inc. Underwriting Agreement

from S-3 42 pages Larimar Therapeutics, Inc. Sales Agreement

from 8-K 47 pages 22,225,000 Shares of Common Stock Larimar Therapeutics, Inc. Underwriting Agreement

from S-3 45 pages Larimar Therapeutics, Inc. Equity Distribution Agreement

from 8-K 42 pages Zafgen, Inc. $50,000,000 Sales Agreement

from 8-K 35 pages Zafgen, Inc. 8,000,000 Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from S-1/A 33 pages Zafgen, Inc. [—] Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from S-1/A 38 pages Zafgen, Inc. [•] Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement